Terms: = Germ cell tumor AND CgA
617 results:
1. Main mechanisms and clinical implications of alterations in energy expenditure state among patients with pheochromocytoma and paraganglioma: A review.
Yang Y; Zhou T; Zhao X; Cai Y; Xu Y; Gang X; Wang G
Medicine (Baltimore); 2024 Apr; 103(17):e37916. PubMed ID: 38669419
[TBL] [Abstract] [Full Text] [Related]
2. Imaging and Histopathological Features Of Primary Thymic Neuroendocrine tumor.
Suwal S; Chen YY; Huang SD; Li WF; Chen H
Curr Med Imaging; 2024; 20():1-8. PubMed ID: 38389359
[TBL] [Abstract] [Full Text] [Related]
3. Plasma tryptophan pathway metabolites quantified by liquid chromatography-tandem mass spectrometry as biomarkers in neuroendocrine tumor patients.
Johansen SU; Hansen T; Nordborg A; Meyer R; Goll R; Florholmen J; Jensen E
J Neuroendocrinol; 2024 Mar; 36(3):e13372. PubMed ID: 38361341
[TBL] [Abstract] [Full Text] [Related]
4. Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM.
Ingenerf M; Karim H; Auernhammer C; Zacherl M; Wenter V; Winkelmann M; Ricke J; Berger F; Schmid-Tannwald C
Radiol Oncol; 2023 Dec; 57(4):436-445. PubMed ID: 38038419
[TBL] [Abstract] [Full Text] [Related]
5. Middle mediastinal paraganglioma: A case report and review of the literature.
Xu S; Hu G; Du J; Ma L; Zou L; Li Q
Medicine (Baltimore); 2023 Nov; 102(47):e36327. PubMed ID: 38013330
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence, one-year-incidence and predictors of carcinoid heart disease.
Mattig I; Franke MR; Pschowski R; Brand A; Stangl K; Knebel F; Dreger H
Cardiovasc Ultrasound; 2023 Sep; 21(1):18. PubMed ID: 37752548
[TBL] [Abstract] [Full Text] [Related]
7. Biomarkers in neuroendocrine neoplasms.
Zouli C; Zisimopoulou E; Chrisoulidou A
Hell J Nucl Med; 2023; 26 Suppl():44-48. PubMed ID: 37658563
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single-center retrospective study.
Zhang Y; Liao JT; Lin Y; Liu C; Wu ZH; Yu B; Sun S; Yu H; Hui XH; Wu XH; Zhao XM; Wang HJ; Zheng Q; Li Y; Hu ZH; Wang JL
J Dig Dis; 2023; 24(8-9):472-479. PubMed ID: 37596865
[TBL] [Abstract] [Full Text] [Related]
11. Gene expression profile of hiPSC-derived cells differentiated with growth factors, forskolin and conditioned medium from human adrenocortical cell line.
Stelcer E; Jopek K; Blatkiewicz M; Olechnowicz A; Kamiński K; Szyszka M; Suchorska WM; Ruciński M
Adv Clin Exp Med; 2024 Apr; 33(4):397-407. PubMed ID: 37540158
[TBL] [Abstract] [Full Text] [Related]
12. [Expression and significance of INSM1 and SOX11 in pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm].
Cao Z; Cen HB; Zhao JH; Mei J; Qin LZ; Liao W; Ao QL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):575-581. PubMed ID: 37534634
[TBL] [Abstract] [Full Text] [Related]
13. The use of deep learning models to predict progression-free survival in patients with neuroendocrine tumors.
Pavel M; Dromain C; Ronot M; Schaefer N; Mandair D; Gueguen D; Elvira D; Jégou S; Balazard F; Dehaene O; Schutte K
Future Oncol; 2023 Oct; 19(32):2185-2199. PubMed ID: 37497644
[No Abstract] [Full Text] [Related]
14. Neuroendocrine tumor chromogranin A response following synthetic somatostatin analog (lanreotide): Early observations from an isolated duodenal neoplasm .
Sills ES; Wood SH; Tan SL; Ibach DM
Neuro Endocrinol Lett; 2023 Jul; 44(4):265-269. PubMed ID: 37466065
[TBL] [Abstract] [Full Text] [Related]
15. [Clinicopathological Features of Primary Small cell Neuroendocrine Carcinoma of the Bladder].
Gu YM; Liang XL; Zhang YG; Zhao HY; Jin ML; Li X; Lu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):429-435. PubMed ID: 37407530
[TBL] [Abstract] [Full Text] [Related]
16. Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up.
Kang Z; Li S; Kang X; Deng J; Yang H; Chen F; Jiang J; Zhang J; Li W
Cancer Biol Med; 2023 Jun; 20(6):465-76. PubMed ID: 37366368
[TBL] [Abstract] [Full Text] [Related]
17. Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms.
Kidess E; Giesecke Y; Eichhorn I; Mohr R; Jann H; Fischer C; Wiedenmann B; Roderburg C; Tacke F; Sigal M
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10925-10933. PubMed ID: 37318593
[TBL] [Abstract] [Full Text] [Related]
18. Atypical thymic carcinoid tumor with ectopic ACTH syndrome in a 33-year-old male patient: A rare case report and literature review.
Li LY; Zhao HY; Tong HC; Li YC; Xu HT; Ma S; Yang LH; Zhang WL; Wildes T; Wang E
Medicine (Baltimore); 2023 Jun; 102(22):e33847. PubMed ID: 37266641
[TBL] [Abstract] [Full Text] [Related]
19. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
20. Mixed adenoneuroendocrine carcinoma of the gallbladder.
Wang Q; Li L; Li J; Fan W
Rev Esp Enferm Dig; 2024 Jan; 116(1):48-49. PubMed ID: 37073699
[TBL] [Abstract] [Full Text] [Related]
[Next]